Cargando…
Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy
In AL amyloidosis complete response (aCR) is defined as negative serum and urine immunofixation with normalized free light chain ratio (FLCR). However, achievement of low levels of involved FLC (iFLC) or difference between iFLC and uninvolved FLC (dFLC) are also relevant endpoints for treatment. We...
Autores principales: | Milani, Paolo, Basset, Marco, Nuvolone, Mario, Benigna, Francesca, Rodigari, Lara, Lavatelli, Francesca, Foli, Andrea, Merlini, Giampaolo, Palladini, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463008/ https://www.ncbi.nlm.nih.gov/pubmed/32873771 http://dx.doi.org/10.1038/s41408-020-00355-6 |
Ejemplares similares
-
The lung in amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017) -
PB2151: CLINICAL FEATURES AND OUTCOMES OF DIFFUSE PULMONARY LIGHT CHAIN AMYLOIDOSIS: A RARE PRESENTATION OF SYSTEMIC AL AMYLOIDOSIS
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023) -
Protease‐sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation
por: Mazzini, Giulia, et al.
Publicado: (2021) -
Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis
por: Lavatelli, Francesca, et al.
Publicado: (2021) -
A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis
por: Sidana, Surbhi, et al.
Publicado: (2020)